Contraception

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 2417-2427

  Glasier, Anna ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890510667     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00134-9     Document Type: Chapter

References (62)

1. Population Reference Bureau www.prb.org 2007 World Population Data Sheet
2. US Department of Health and Human Services www.cdc.gov/nchs/data/series/sr_23/sr. Fertility, family planning and reproductive health of US women: Data from the 2002 National Survey of Family Growth. DHHS Publication No 9 (PHS) 2006–1977
3. JJ Frost, S Singh and LB Finer (2007) US women's one-year contraceptive use patterns. Perspect Sex Reprod Health 39 48-55.
4. N Bajos, H Leridon, H Gowlard, et al. (2003) Contraception: from accessibility to efficiency. Hum Reprod 18 994-999. and the COCON Group
5. BJ Oddens and I Milsom (1996) Contraceptive practice and attitudes in Sweden 1994. Acta Obstet Gynecol Scand 75 932-940.
6. JS Santelli, L Duberstein Lindberg, LB Finer, et al. (2007) Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health 97 1-7.
7. RK Jones, JE Darroch and SK Henshaw (2002) Contraceptive use among US women having abortions in 2000–2001. Perspect Sex Reprod Health 34 294-303.
8. J Trussel (2007) Contraceptive Efficacy. RA Hatcher, J Trussell, A Nelson, et al., (Eds) Contraceptive Technology ed 19 New York: Ardent Media 759.
9. A Rosenberg and MS Waugh (1999) Causes and consequences of oral contraceptive non-compliance. Am J Obstet Gynecol 180 276-279.
10. L Potter, D Oakley, E de Leon-Wong, et al. (1996) Measuring compliance among oral contraceptive users. Fam Plann Perspect 28 154-158.
11. C D’Arcangues, V Odlind and IS Frasier (1992) Dysfunctional uterine bleeding induced by exogenous hormones. MJ Alexander, C D’Arcangues,(Eds) Steroid hormones and uterine bleeding Washington, DC: AAAS Press 81-105.
12. WR Grady, JOG Bill and DH Klepinger (2002) Contraceptive method switching in the United States. Perspect Sex Reprod Health 34 135-145.
13. F Lakha and A Glasier (2006) Continuation rates of Implanon in the UK: Data from an observational study in a clinical setting. Contraception 74 287-289.
14. SJ Emans, E Grace, ER Woods, et al. (1987) Adolescent's compliance with the use of oral contraceptives. JAMA 257 3377-3381.
15. G Larsson, F Blohm, G Sundell, et al. (1997) A longitudinal study of birth control and pregnancy outcome among women in a Swedish population. Contraception 56 6-16.
16. World Health Organization (2008) Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use. ed 4 Geneva: Reproductive Health and Research, WHO www.who.int/reproductive-health/publications/index.htm
17. MJ Rosenburg, MS Waugh and TE Meehan (1995) Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 51 283-288.
18. J Courtland Robinson, S Plichta, CS Weisman, et al. (1992) Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am J Obstet Gynecol 166 578-583.
19. ESHRE Capri Workshop Group (2005) Non-contraceptive benefits of combined oral contraception. Hum Reprod Update 11 513-525.
20. V Beral, R Doll, C Hermon, et al. (2008) Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraception: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371 303-314.
21. AM Flynn (1991) Natural methods of contraception. Matern Child Health J 16 148-153.
22. M Labbok, P Koniz-Booher, K Cooney, et al. (1990) Guidelines for breastfeeding in family planning and child survival programs. Washington DC: Institute for Studies in Natural Family Planning
23. A Perez, M Labbok and J Queenan (1992) Clinical study of the lactational amenorrhoea method for family planning. Lancet 339 968-969.
24. W Cates Jr (2001) The NIH Condom Report: The glass is 90% full. Fam Plann Perspect 33 231-233.
25. C Mauck, M Calahan, D Weiner, et al. (1999) A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm. Contraception 60 71-80.
26. World Health Organization (2001) WHO/CONRAD Technical Consultation on Nonoxynol-9. Geneva: WHO http://www.who.int/reproductivehealth/publications/nonoxynol9/nonoxynol9.pdf
27. D Hubacher (2002) The checkered history and bright future of intrauterine contraception in the United States. Perspect Sex Reprod Health 34 98-103.
28. Special issue on intrauterine devices and systems. Contraception 75 S1-S116. Multi-authors
29. United Nations Development Programme/United Nations Population Fund/ World Health Organization/World Bank Special Programme of Research (1997) Long-term reversible contraception. Twelve years of experience with the Tcu380A, and Tcu220C. Contraception 56 341-352.
30. I Sivin (1991) Dose and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 78 291-298.
31. DA Grimes (2001) Intrauterine devices and infertility: sifting through the evidence. Lancet 358 6-7.
32. D Archer, JT Jensen, JV Johnson, et al. (2006) Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 74 439-445.
33. MC Audet, M Morean, WD Koltun, et al. (2001) Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch versus an oral contraceptive. A randomized controlled trial. JAMA 285 2347-2354. for the ORTHO/EVRA study group
34. RJ Bjarnadottir, M Tuppurainen and SR Killick (2002) Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 186 389-395.
35. AM Kaunitz, RJ Garceau and MA Cromie Lunelle Study Group (1999) Comparative safety, efficacy and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Contraception 60 179-187.
36. V Beral, C Hermon, C Kay, et al. (1999) Mortality associated with oral contraceptive use: 25 year follow up of a cohort of 46,000 women from Royal College of General Practitioners’ oral contraception study. Brit Med J 318 96-100.
37. PC Hannaford, S Selvaraj, AM Elliot, et al. (2007) Cancer risks among users of oral contraceptives: cohort data from the Royal College of General Practitioners Oral Contraception Study. BMJ 335 651-659.
38. AB Berenson, SD Odom, CR Breitkopf, et al. (2008) Physiological and psychological symptoms associated with use of injectable contraception and 20 µg oral contraceptive pills. Am J Obstet Gynecol [epub ahead of print]
39. MF Gallo, DA Grimes, KF Schultz, et al. (2004) Combination estrogen-progestin contraceptives and body weight. Systematic review of randomized controlled trials. Obstet Gynecol 103 359-373.
40. DF Hassan, CA Petta, JM Aldrighi, et al. (2003) Weight variation in a cohort of women using copper IUD for contraception. Contraception 68 27-30.
41. J Endrikat, C Gerlinger, M Cronin, et al. (2001) Blood pressure stability in a normotensive population during intake of monophasic oral contraceptive pills containing 20 µg ethinyl oestradiol and 75 µg desogestrel. Eur J Contracept Reprod Health Care 6 159-166.
42. DCG Skegg (2000) Third generation oral contraceptives. BMJ 321 190-191.
43. J Rosing, S Middeldorp, J Curvers, et al. (1999) Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 354 2036-2040.
44. AL Nightingale, RA Lawrenson, EL Simpson, et al. (2000) The effect of age, body mass index, smoking and general health on the risks of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care 5 265-274.
45. YS Khader, J Rice, L John, et al. (2003) Oral contraceptive use and risk of myocardial infarction: a meta-analysis. Contraception 68 11-17.
46. WS Chan, J Ray, EK Wai, et al. (2004) Risk of stroke in women exposed to low dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 164 741-747.
47. KM Curtis, AP Mohllajee and HB Peterson (2006) Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 73 189-194.
48. The Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: a collaborative re-analysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347 1717-1727.
49. PA Marchbanks, JA McDonald, HG Wilson, et al. (2002) Oral contraceptives and the risk of breast cancer. New Engl J Med 346 2025-2032.
50. International Collaboration of Epidemiological Studies on Cervical Cancer (2007) Cervical cancer & hormonal contraceptives: collaborative reanalysis of data from 16573 women with and 35509 women without cervical cancer from 24 epidemiological studies. Lancet 370 1609-1621.
51. CF Rice, SR Killick, T Dieben, et al. (1999) A comparison of the inhibition of ovulation achieved by desogestrel 75 µg and levonorgestrel 30 µg daily. Hum Reprod 14 982-985.
52. Implantable contraceptives for women. Contraception 65 1-119.
53. MK Clark, JS Dillon, M Sowers and S Nichols (2005) Weight, fat mass and central distribution of fat increase when women use depo-medroxyprogesterone acetate for contraception. Int J Obesity 29 1252-1258.
54. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1998) Cardiovascular Disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international multicentre case-control study. Contraception 57 315-324.
55. C Vasilakis, H Jick and M del Mar Melero-Montes (1999) Risk of idiopathic venous thromboembolism in users of progestogens alone. Lancet 354 1610-1611.
56. International Collaborative Post-Marketing Surveillance of Norplant (2001) Post-Marketing Surveillance of Norplant® contraceptive implants: II. Non-reproductive health. Contraception 63 187-209.
57. World Health Organization (2005) Technical Consultation on Hormonal Contraception and Bone Health. Geneva: WHO http://www.who.int/reproductive-health/publications/hc_bonehealth/consultation_rpt.pdf
58. MK Clark, M Sowers, B Levy, et al. (2006) Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 86 1466-1474.
59. World Health Organization (2002) Improving Access to Quality Care in Family Planning. Selected Practice Recommendations. Geneva: WHO, Reproductive Health and Research http://www.who.int/reproductive-health/publications/index.htm
60. American College of Obstetrics and Gynecologists (2005) Emergency Contraception. ACOG Practice Bulletin No. 69. Clinical Management Guidelines for Obstetricians & Gynecologists. Obstet Gynecol 106 1443-1452.
61. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit (2006) Emergency Contraception. J Fam Plann Reprod Health Care 32 121-128.
62. CB Polis, K Schaffer, K Blanchard, et al. (2007) Advance provision of emergency contraception for pregnancy prevention: A meta-analysis. Obstet Gynecol 110 1379-1388.